Electromed (ELMD) EBIAT (2016 - 2025)
Electromed (ELMD) has disclosed EBIAT for 16 consecutive years, with $2.8 million as the latest value for Q4 2025.
- On a quarterly basis, EBIAT rose 40.29% to $2.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $9.0 million, a 32.96% increase, with the full-year FY2025 number at $7.5 million, up 46.35% from a year prior.
- EBIAT was $2.8 million for Q4 2025 at Electromed, up from $2.1 million in the prior quarter.
- In the past five years, EBIAT ranged from a high of $2.8 million in Q4 2025 to a low of $81000.0 in Q3 2022.
- A 5-year average of $1.2 million and a median of $1.1 million in 2023 define the central range for EBIAT.
- Peak YoY movement for EBIAT: tumbled 81.55% in 2022, then soared 850.97% in 2024.
- Electromed's EBIAT stood at $838000.0 in 2021, then increased by 16.59% to $977000.0 in 2022, then skyrocketed by 71.34% to $1.7 million in 2023, then increased by 17.56% to $2.0 million in 2024, then soared by 40.29% to $2.8 million in 2025.
- Per Business Quant, the three most recent readings for ELMD's EBIAT are $2.8 million (Q4 2025), $2.1 million (Q3 2025), and $2.2 million (Q2 2025).